OpenAI acquires Orchestra Bio

来源简介

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

本条尚未生成中文 AI 摘要，以上展示来源提供的原始简介。
采集于 2026/10/21 02:34:33（北京时间）。